Brooklyn Investment Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
Brooklyn Investment Group's MRNA Position: Q1 2026 in Review
Brooklyn Investment Group increased its Moderna (MRNA) stake by 26% in Q1 2026, buying an estimated $223K and bringing the position to 23,110 shares worth $1.17M. The position accounts for 0.04% of the portfolio, ranked #483.
Brooklyn Investment Group first reported a position in MRNA in Q3 2024 and has held it in 6 quarters since. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Brooklyn Investment Group held 23,110 shares of Moderna worth $1.17M as of Q1 2026.
- Brooklyn Investment Group bought 4,777 Moderna shares in Q1 2026, an estimated $223K.
- Moderna made up 0.04% of Brooklyn Investment Group's portfolio in Q1 2026, its #483 holding.
- Brooklyn Investment Group first reported a position in Moderna in Q3 2024 and has held it in 6 quarters since.
- 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.